INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Navigating Regulatory Expectations For Injectable Packaging
Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.
-
Integration Of Container Closure Integrity In Contract Manufacturing
Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
The Enhanced Version Of Ready-To-Use Vial Platform
Discover a platform for aseptic manufacturing that offers pre-sterilized vials for biologics to improve efficiency and safety with automated filling systems and advanced packaging for optimized drug containment.
-
Autoinjectors For Autoimmune Diseases: Benefits And Considerations
By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.
-
Improve Speed To Market By Mitigating Vial And Stopper Incompatibility10/1/2024
These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.
-
Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals10/24/2024
Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.
-
Reducing Risks By Outsourcing OSD Manufacturing And Packaging10/23/2024
Watch to discover the key benefits of outsourcing your OSD production and explore real-world examples and best practices to help you streamline your processes and enhance your operational agility.
-
Understanding Injectable Drug Container Closure Systems6/20/2024
Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.
-
De-Risking The Transition From Vial To Drug-Device Combination Product7/25/2025
When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
We provide a flexible and dynamic approach to GMP manufacturing. From first in human (FIH) through to phase 3 clinical supplies manufacturing at our MHRA Approved and Home Office Approved (I-IV) GMP facility, Trent Gateway.
-
Our solid forms plant exports 75% of its output, supplying products to 45 markets in 25 different languages.
-
Used CVC wrap around labeler, model 302C, with dual bump feed wheels, wrap station and PLC controls, 220 volt, serial# 09603075, built 2007.
-
Ropack Pharma Solutions is equipped to produce sachets in a range of fills, including powder, liquid/cream and solid dosage fill of one or two different products per sachet.
-
Harnessing decades of global drug product development and commercialization, you can rely on PCI's integrated speed solutions to simplify the supply chain.